Biocon Sdn. Bhd.

Importer · Malaysia

Biopharmaceutical Manufacturing

About Biocon Sdn. Bhd.

Biocon Sdn. Bhd., a subsidiary of Biocon Biologics, operates Asia's largest integrated insulin manufacturing and R&D facility in Malaysia. Established with an investment of over USD 350 million, the facility produces recombinant human insulin and insulin analogs, serving both local and global markets. Biocon Sdn. Bhd., a subsidiary of Biocon Biologics, operates Asia's largest integrated insulin manufacturing and R&D facility in Malaysia. Established with an investment of over USD 350 million, the facility produces recombinant human insulin and insulin analogs, serving both local and global markets. BioCon Biologics BioCon Biologics Company LinkedIn URL: Not Available